No Data
No Data
PPL Corporation to Conduct Webcast on Third-Quarter 2024 Earnings Results
Institutional Investors in PPL Corporation (NYSE:PPL) Lost 3.9% Last Week but Have Reaped the Benefits of Longer-term Growth
Piramal Pharma Releases Its Sustainability Report for FY 2023-24 Under the Theme, 'Building Resilience for a Sustainable Tomorrow'
PPL Corporation (NYSE:PPL) Is Largely Controlled by Institutional Shareholders Who Own 78% of the Company
Is It Too Late To Consider Buying PPL Corporation (NYSE:PPL)?
Morgan Stanley Maintains PPL Corp(PPL.US) With Buy Rating, Raises Target Price to $35
No Data
No Data